Supply of BinaxNOW COVID-19 Antigen Test Kits (COTS)

The contract is for the manufacture and delivery of BinaxNOW COVID-19 antigen test kits authorized by the FDA for over-the-counter, at-home use, with all packaging required to meet regulatory compliance and ensure a minimum shelf life of 12 months. The kits must be produced and packaged to stringent quality and safety standards to support widespread public health use without the need for professional administration. This is a subcontract under the Department of Defense via the Medical Supply Chain MD Surg FSF, with performance designated to a military post office address in FPO, ZIP 96662, reflecting its role in supporting federal and military health readiness. The solicitation was posted on May 13, 2026, with a response deadline of May 19, 2026, and is classified under NAICS code 325412, which pertains to pharmaceutical and medicinal manufacturing. The procurement is part of a broader effort to secure reliable, scalable, and timely access to diagnostic tools for domestic and expeditionary use, aligning with Defense Department supply chain initiatives. All deliveries must meet exact specifications for labeling, storage, and distribution to ensure the integrity and usability of the tests in varied environmental conditions, and any noncompliance with shelf life or regulatory requirements will result in rejection of the product.